Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Adrenocortical CarcinomaPeritoneal Carcinomatosis
Interventions
DRUG

Cisplatin

"Route of administration: Intraperitoneal for tumor treatment. Dose of 250 mg/m2~Drug 1 of the hyperthermic intraperitoneal chemotherapy (HIPEC)"

DRUG

Sodium thiosulfate

"Route of administration: Intravenous Loading dose of 7.5 gm/m2 over 20 minutes followed by 2.13 gm/m2/hr for 12 hours~Drug 2 given intravenously during hyperthermic intraperitoneal chemotherapy (HIPEC)"

PROCEDURE

Cytoreductive surgery

Standard of care: Surgical procedure used to remove tumors from patients with peritoneal tumors.

Trial Locations (1)

10032-3729

RECRUITING

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER